|
|
||||||||
1 Department of Medicine, and 2 Department of Human Services, University of Virginia, Charlottesville, Virginia 22903
| |
ABSTRACT |
|---|
|
|
|---|
We examined gender differences in growth hormone
(GH) secretion during rest and exercise. Eighteen subjects (9 women and
9 men) were tested on two occasions each [resting condition (R) and exercise condition (Ex)]. Blood was sampled at 10-min
intervals from 0600 to 1200 and was assayed for GH by
chemiluminescence. At R, women had a 3.69-fold greater mean calculated
mass of GH secreted per burst compared with men (5.4 ± 1.0 vs. 1.7 ± 0.4 µg/l, respectively) and higher basal (interpulse) GH
secretion rates, which resulted in greater GH production rates and
serum GH area under the curve (AUC; 1,107 ± 194 vs. 595 ± 146 µg · l
1 · min,
women vs. men; P = 0.04).
Compared with R, Ex resulted in greater mean mass of GH secreted per
burst, greater mean GH secretory burst amplitude, and greater GH AUC
(1,196 ± 211 vs. 506 ± 90 µg · l
1 · min,
Ex vs. R, respectivley; P < 0.001).
During Ex, women attained maximal serum GH concentrations significantly
earlier than men (24 vs. 32 min after initiation of Ex, respectively;
P = 0.004). Despite this temporal
disparity, both genders had similar maximal serum GH concentrations.
The change in AUC (adjusted for unequal baselines) was similar for men
and women (593 ± 201 vs. 811 ± 268 µg · l
1 · min),
but there were significant gender-by-condition interactive effects on
GH secretory burst mass, pulsatile GH production rate, and maximal
serum GH concentration. We conclude that, although women exhibit
greater absolute GH secretion rates than men both at rest and during
exercise, exercise evokes a similar incremental GH response in men and
women. Thus the magnitude of the incremental secretory GH response is
not gender dependent.
sex steroids; deconvolution analysis; endocrinology; human
| |
INTRODUCTION |
|---|
|
|
|---|
GROWTH HORMONE (GH) release at rest is greater in young women than in comparably aged men (5, 27, 28). By deconvolution analysis, daily GH secretion rates are as much as 1.5- to 2.5-fold higher in young women than in age-matched men, and this gender difference is accounted for by a twofold greater mass of GH secreted per burst (28). In addition, increases in basal interpulse GH secretion rates characterize young women (28). Studies in rats (17) have shown a more nearly continuous GH release pattern in females, whereas males have a more pulsatile GH release pattern. Recently, Pincus et al. (18) reported analogously more orderly GH release patterns in men than women. The gender difference in GH release patterns may be caused by increased GH-releasing hormone (GHRH) responsiveness or by reduced somatostatin inhibitory tone in women (28).
Aerobic exercise is a powerful physiological stimulus of GH release (11, 15, 20, 26, 34-36). Although the mechanisms underlying exercise-induced GH release have not been elucidated fully, they likely include GHRH release, somatostatin withdrawal, natural ligand release [i.e., GH-releasing peptide (GHRP)], or a combination of these hypothalamic responses. Although a single previous study reported that men and women have similar qualitative patterns of exercise-induced GH release (15), gender differences in the magnitude of the GH secretory response to aerobic exercise have not been investigated by frequent sampling and deconvolution techniques. Gender differences in exercise-induced GH release could result in different patterns of circulating GH during exercise; these patterns may influence metabolism during and after an aerobic exercise bout. Because exercise is a potent stimulus for GH release, we hypothesized that exercise would override the gender differences observed at rest and that the exercise-induced GH release would be similar in men and women. Given the foregoing issues, the purpose of the present study was to examine gender differences in deconvolution-estimated GH secretion rates during acute constant-load aerobic exercise.
| |
METHODS |
|---|
|
|
|---|
Eighteen healthy subjects [9 men (age, 25 ± 1.5 yr; ht, 178 ± 1.0 cm; wt, 75.1 ± 1.8 kg) and 9 women (age, 25 ± 1.0 yr; ht, 169 ± 2.0 cm; wt, 66.5 ± 3.1 kg)] voluntarily participated in this study. All subjects underwent a detailed medical history and physical examination and provided written informed consent as approved by the Human Investigation Committee at the University of Virginia. Subjects were not taking any medications or hormones and were habitual exercisers (20-30 min of aerobic exercise, 3-4 times/wk).
Body density was measured by hydrostatic weighing (12). Residual lung volume was measured by using an oxygen-dilution technique (37). Each subject was weighed in air on an Accu-weigh beam scale accurate to 0.1 kg and weighed underwater on a Chatillon autopsy scale accurate to 10 g. Percent body fat was calculated by using the equation of Brozek et al. (1).
Subjects also completed a peak oxygen consumption
(
O2 peak)-lactate
threshold (LT) test on a cycle ergometer. Initial power output was 40 W
for women and 60 W for men, and the power output (PO) was increased 15 W every 3 min until volitional fatigue. Metabolic measures were
collected by using standard open-circuit spirometric techniques
(metabolic cart 2700Z; Sensormedics, Yorba Linda, CA). Heart rate was
determined by electrocardiogram. An indwelling venous cannula was
inserted in a forearm vein, and blood samples were taken at rest and
during the last 15 s of each stage for the measurement of blood lactate
concentration (model 2700; YSI Instruments, Yellow Springs, OH). The LT
was determined from the blood lactate-PO relationship (34). The PO for
the constant-load aerobic exercise sessions (CLPO) was
calculated as follows
|
GH concentrations in all serum samples (0600-1200, both admissions) were measured in the GCRC Core Laboratory by using an ultrasensitive (0.002 µg/l threshold) chemiluminescence assay (Nichols, San Juan Capistrano, CA). The chemiluminescent assay detects predominantly the 22-kDa form of GH. The cross-reactivity for 20 kDa GH (methionated) in this assay is 33.8%. The addition of recombinant GH binding protein (rGHBP) in the physiological range resulted in a 10-20% reduction in measured GH; this indicates that rGHBP competes modestly with the assay antiserum for binding sites on the GH molecule. Intra-assay coefficient of variation (CV) for the GH assay was 6.0%, whereas the interassay CV was 9.9%. Total testosterone, free testosterone, and estradiol concentrations were measured in the GCRC Core Laboratory by using a solid-phase radioimmunoassay (RIA) (Coat-a-Count; Diagnostic Products, Los Angeles, CA). The intra-assay CVs were 6.9, 3.8, and 3.9% for total testosterone, free testosterone, and estradiol, respectively, whereas the interassay CVs were 10.3, 4.2, and 9.5%, respectively. IGF-I was measured by RIA (Nichols). The intra-assay CV for IGF-I was 6.7%, and the interassay CV was 13.6%.
Total GH area under the curve (AUC) was calculated by using the
trapezoidal rule (31). The change in AUC (
AUC) was calculated thereafter by subtracting the AUC for the resting admission from the
AUC for the aerobic exercise admission for each subject.
A multiple-parameter deconvolution method was employed to derive quantitative estimates of attributes of GH secretion from the measured serum GH concentrations. The subject-specific monoexponential half-life of apparent metabolic removal of endogenous GH was estimated concurrently (30). The procedure for deconvolution entails prefitting via an automated waveform-independent technique (PULSE2), in which regions that contain significant secretion impulses of undefined waveform are identified successively within the time series by their ability to significantly reduce the total fitted variance by F ratio testing (10). Peak locations from PULSE2 were used as estimates in the multiparameter deconvolution analysis, which followed a set fitting pathway, as previously described (4, 33).
To avoid overdetermination of peaks (Nyquist concept), GH peaks that were closer than 20 min (2 sampling intervals apart) were eliminated from the file, and the data were refit. In addition, any peaks that were outside the sampling window (0-370 min) by more than one sample interval (10 min) were eliminated from the file. A pulse of GH secretion was approximated algebraically by a Gaussian distribution of secretory rate (30). Basal secretion (time invariant) was estimated concurrently, as previously described (33). GH secretory pulses were considered significant if the fitted amplitude (maximal value attained within the computed secretory event) could be distinguished from zero with 95% statistical confidence. The half duration of the GH secretory pulse (defined as the duration in minutes of the calculated secretory burst event at half-maximal amplitude), GH half-life of elimination, and GH distribution volume were assumed to be constant throughout any one study period for an individual. The mass of GH secreted per pulse was estimated as the area of the calculated secretory pulse (in µg/l distribution volume) (30). The endogenous pulsatile GH production rate was defined as the product of the number of GH secretory pulses and the mean mass of GH secreted per pulse.
A two-way nested ANOVA model was used to analyze condition and gender
effects for GH AUC, GH secretion parameters, and concentrations of
serum sex-steroids and IGF-I. ANOVA computations were carried out by
using the mixed model procedure (Proc Mixed in SAS version 6.12 SAS/STAT Software Changes and Enhancements, 1996). Model parameters
were estimated by restricted maximum likelihood (8), and 95%
confidence limits were estimated by least significant difference (LSD)
criteria (13). All outcomes were analyzed on the natural log scale to
attain equal variance among groups. P values presented from the ANOVA are for comparisons made on the log-transformed data. Gender differences in the constant-load exercise
data and the time to maximal GH concentration were tested by using an
unpaired Student's t-test. Linear
regression was applied to investigate the relationship between maximal
serum GH concentration and GH half-life. Statistical significance was
interpreted as P
0.05.
| |
RESULTS |
|---|
|
|
|---|
Gender comparisons for total body fat,
O2 peak and
constant-load aerobic exercise data are presented in Table
1. Men had a greater absolute
O2 peak (in l/min)
compared with women, but there was no gender difference in relative
O2 peak peak
(ml · kg
1 · min
1),
the CLPO, the PO at LT, or the maximal PO obtained. The CLPO expressed
as a percentage of the maximal PO was 72%. During the constant-load
aerobic exercise, men and women did not differ in the total work
completed in 30 min, the final blood lactate concentration, or the
total energy expended. Although the
O2 peak attained in the last 2 min of aerobic exercise was significantly greater in men than women, the end-aerobic exercise oxygen consumption (
O2) expressed as a
percentage of
O2 peak
was similar in both genders (Table 1).
|
The visually evident pattern of the serum GH concentration response
during rest and aerobic exercise was similar in men and women (Figs.
1 and 2,
respectively). The time to reach the maximal GH concentration during
exercise was greater in men than women (men attained peak serum GH
concentrations 32 min after the initiation of exercise, whereas women
achieved peak GH concentrations 24 min into the 30-min constant-load
exercise bout, P = 0.004). During aerobic exercise, both men and women responded with increased GH
release, and the maximal serum GH obtained was greater in women than
men. However, the relative increase in GH concentration observed for
men (5.8-fold, 95% CI 3.9-8.6) was significantly greater than the
increase observed for women (3.2-fold, 95% CI 2.2-4.8; P = 0.043). Linear regression analysis revealed that the maximal GH concentration attained did not significantly influence the GH half-life, as measured by deconvolution analysis.
|
|
Figure 3 shows GH AUC and
AUC for men
and women at rest and in response to aerobic exercise. GH AUC increased
from 506 ± 90 µg · l
1 · min
during the resting admission to 1,196 ± 211 µg · l
1 · min
during the aerobic-exercise admission (pooled gender data; P < 0.001). Women had greater GH AUC
compared with men [1,107 ± 194 vs. 595 ± 146 µg · l
1 · min,
respectively (pooled rest/aerobic exercise data);
P = 0.042]. The
AUC for women
was 811 ± 268 µg · l
1 · min
and the
AUC for men was 593 ± 201 µg · l
1 · min
(P = 0.53).
|
Representative GH concentration curves for two men and two women are
depicted in Fig. 4, whereas Fig.
5 shows the GH secretion profiles from
deconvolution for the same subjects. Table
2 shows specific GH secretion measures for
men and women during rest and exercise. GH basal (interpulse) secretion
was significantly greater in women than in men (0.012 ± 0.002 vs.
0.006 ± 0.001 µg · l
1 · min
1,
respectively; P = 0.043) and was not condition dependent (i.e., resting and aerobic exercise admissions had similar GH basal
secretion). There were no significant differences in GH half-life or
half duration of GH burst. Although women had greater pulsatile GH production rates compared with men at rest (34.9 ± 8.3 vs. 10.5 ± 3.1 µg · l
1 · 6 h, for women and men, respectively) and during exercise (63.3 ± 12.7 vs. 36.9 ± 9.2 µg · l
1 · 6 h, for women and men, respectively), the relative increase in pulsatile
GH production rate between rest and exercise was greater in men
(3.5-fold, 95% CI 2.6-5.7) compared with women (1.8-fold, 95% CI
1.2-2.7; P = 0.009). In both women
and men, the increase in pulsatile GH production rate observed during
exercise was due to an increase in mean mass of GH secreted per burst, as the number of GH peaks was significantly reduced by exercise (6 vs.
5, P = 0.024). As was observed with
pulsatile GH production rate, the relative increase in mean mass of GH
secreted per burst between rest and exercise was greater in men
(5.1-fold, 95% CI 3.2-9.2) compared with women (2.2-fold, 95% CI
1.4-3.5; P = 0.016). Mean GH burst
amplitude was greater in women compared with men (P = 0.027) and during exercise
compared with rest (P < 0.001). A
trend was observed for a greater relative increase in mean GH burst
amplitude between rest and exercise in men (6.6-fold, 95% CI
3.6-12.0) compared with women (3.1-fold, 95% CI 1.7-5.6;
P = 0.077).
|
|
|
The concentrations of serum IGF-I and sex steroids are presented in
Table 3. Total and free testosterone
concentrations were greater in men than in women
(P < 0.001 and
P < 0.001, respectively). There was
no difference in the concentration of total or free testosterone during
the rest compared with the aerobic exercise admissions
(P = 0.152 and
P = 0.245, respectively). Serum
estradiol and IGF-I concentrations were similar in men and women
(P = 0.069 and
P = 0.852, respectively) and on the
aerobic exercise vs. rest days (P = 0.630 and P = 0.577, respectively).
|
| |
DISCUSSION |
|---|
|
|
|---|
Gender differences in pulsatile GH release exist, but such gender distinctions have been recognized in the resting condition only (7, 18, 27, 28). In the present study, we examined gender differences in GH release during rest and constant-load aerobic exercise. Our analyses show that women have greater basal (interpulse) GH secretion and serum GH AUC compared with men, independent of condition (Table 2). The higher serum GH AUC and calculated GH (pulsatile) production rate in women reflected a greater mean mass of GH secreted per burst compared with men during both rest and aerobic exercise. During exercise, augmentation of the mean mass of GH secreted per burst resulted in greater GH AUC and GH production rate, compared with rest in both genders (Table 2). Serum GH AUC (or GH secretion rate) was not affected by estradiol, total or free testosterone, or IGF-I (Table 3).
Gender differences in calculated baseline (resting) GH secretion and serum GH AUC were previously noted by several investigators (7, 18, 27). In support of data previously reported by van den Berg et al. (27), who used an immunofluorometric assay, women in the present study had higher basal serum GH concentrations than did men (Table 2), as assessed in a chemiluminescence assay. The 24-h GH AUC also is higher in young women than in young men, and the magnitude of the difference is approximately twofold (7, 27, 28). Although serum GH AUC in the current study represents data collected for only 6 h, women had significantly greater GH AUC, and the magnitude of the disparity was similar to that reported for 24-h GH AUC (~2-fold). Serum GH concentrations in the present study (Figs. 1 and 2) at rest were uniformly measurable for the first time in both men and women in the ultrasensitive GH assay employed here, unlike earlier RIA (5) or immunofluorometric assays (18, 27).
As expected, aerobic exercise elicited a greater serum GH AUC compared
with the resting admission (Fig. 3). This finding supports data from
previous studies that indicate that aerobic exercise of appropriate
intensity and duration is a powerful, effective, physiological stimulus
for GH release (11, 15, 20, 35, 36). However, as documented in other
studies (11, 15, 20, 26, 34, 35), the maximal aerobic exercise-induced
GH concentration is variable among subjects (Fig. 4). This variability
was not gender specific and was not due to the intensity of aerobic
exercise, because all subjects worked at the same intensity relative to their LT and maximal exertion (~75% of their individual
O2 peak), for
the constant-load aerobic exercise session. The biological variability
in the GH response to exercise is similar to that observed with
multiple other GH stimulation tests (i.e.,
L-arginine, L-3,4-dihydroxyphenylalanine,
clonidine) (5).
Despite gender differences in the absolute values of GH release during
rest and aerobic exercise, the pattern of aerobic exercise-induced GH
release was similar in men and women. As previously described in humans
(15, 20, 25, 26), both genders attained maximal serum GH concentrations
at or near the end of the 30-min aerobic exercise bout, and GH levels
returned to baseline within 90 min of the termination of exercise (Fig.
2). We are not aware of any other studies that compare in men and women
the pattern of acute exercise-induced, short-term (6 h) GH release.
Although Lassarre et al. (15) reported that women and men had similar
chronologies of GH release, the authors did not present any data for
women. In the present study, women achieved peak serum GH concentration significantly earlier in the exercise bout than did men (24 vs. 32 min). Although women had higher serum GH concentrations at rest and
during exercise and attained their peak GH concentration sooner than
men, the fold increase in GH concentration was significantly greater in
men compared with women (5.8- vs. 3.2-fold). The
AUC and the
incremental magnitude of the aerobic exercise-induced rise in GH
secretion were similar in men and women (Fig. 3). We speculate that the
lower absolute GH AUC observed during rest and exercise in men, without
detrimental effects on muscle mass and fat patterning, is offset by the
combined anabolic effects exerted by testosterone and GH on target tissues.
In the present study, GH AUC and calculated pulsatile GH production rate were greater in women than men. This was attributable to an increased mean mass of GH secreted per burst in women. These results are similar qualitatively to 24-h data reported previously (18, 27), but they represent the first such gender comparison in an ultrasensitive chemiluminescence-based GH assay (29). Mean GH burst amplitude was greater in women compared with men in the present study, akin to previous 24-h observations (28). There was no gender difference in GH secretory pulse number, half duration, or half-life. Previous reports suggest that gender does not affect pulse number (7, 27, 34), and GH half-life has been reported to be gender-independent (23).
The increases in serum GH AUC and calculated GH production rate during aerobic exercise were due to augmentation of the mean mass of GH secreted per burst, which in turn reflects the mean GH secretory burst amplitude. Kanaley et al. (11) also observed a rise in the mean mass of GH secreted per burst (and the mean GH burst amplitude) with repeated acute aerobic exercise. We did not identify a decrease in apparent GH half-life during aerobic exercise compared with rest. Although this finding is similar to that of Kanaley et al., both results differ from other findings (15, 26). This may be due to the fact that the GH half-life observed at rest in the present study was shorter than that observed in other studies and was calculated on the basis of a chemiluminescence assay measurements of basal release (32). However, it falls within the normal range of biologically acceptable GH half-life values measured directly (22).
Because sex steroid hormones and IGF-I have been shown to affect GH release in a variety of ways (2, 7, 14, 28), the concentrations of these hormones were measured in each study session, and the possible contributions to differences in GH release were assessed. As expected, total and free testosterone concentrations were significantly greater in men than in women, but there was no difference within gender in the concentrations on the rest or aerobic exercise day. Estradiol concentrations were similar in men and women, probably because all women were studied in the early follicular phase of the menstrual cycle, when estradiol levels are lowest. Serum IGF-I concentrations were similar in the resting and aerobic exercise admissions as well as in men and women. Aerobic exercise can result in acute GH-independent increases in serum IGF-I levels (2), but IGF-I concentrations in the present study were measured only at time 0 before aerobic exercise. Although gender differences in aerobic exercise-induced changes in serum IGF-I concentrations might exist, this question was not addressed in the present study.
The actual mechanisms by which aerobic exercise-induced GH secretion occurs are still unclear. In a rat model, with GH assessed in a growth-plate bioassay, afferent neural excitation during exercise signaled release of GH from the pituitary (6). Various neurotransmitters (such as norepinephrine, acetylcholine, and opioids) also have been suggested as playing roles in the control of aerobic exercise-induced GH secretion (3, 16, 24, 27). However, no one mechanism has been proven to be primary. Probably several neurotransmitters are involved (5). However, the final common pathway presumptively involves either increased release of GHRH, decreased release of somatostatin, or a combination of both. The recent cloning of the GHRP receptor (9, 19), and the possibility that an endogenous GHRP-like molecule will be isolated, allow the consideration that the putative GHRP system also can serve to regulate aerobic exercise-induced GH secretion. Thus the mechanisms underlying aerobic exercise-induced GH secretion must be investigated more extensively.
In conclusion, the present study substantiates that 30 min of aerobic exercise at an intensity above the LT constitute an effective physiological stress for GH release in both men and women. The present data show that, regardless of gender differences in baseline serum GH concentrations, basal pulsatile GH secretion (as assessed by deconvolution analysis) and the time to reach the maximal serum GH concentration, the magnitude of the (incremental) increase in GH release that is induced by aerobic exercise is similar in both men and women.
| |
ACKNOWLEDGEMENTS |
|---|
The authors acknowledge the following for invaluable contributions to the project: Sandra Jackson and the nurses in the GCRC for blood draws and patient care; Jim T. Patrie for statistical analysis; and Ginger Bauler, Katherine Kern, and Eli Casarez for performing the GH chemiluminescent and other RIAs.
| |
FOOTNOTES |
|---|
This study was supported in part by GCRC Grant RR-00847, the National Science Foundation Center for Biological Timing, and National Institute on Aging Grant R01-AG-147991 (to J. D. Veldhuis).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: A. Weltman, Exercise Physiology Laboratory, Memorial Gymnasium, Univ. of Virginia, Charlottesville, VA 22903 (E-mail: alw2v{at}virginia.edu).
Received 30 March 1998; accepted in final form 11 May 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Brozek, J.,
F. Grande,
J. T. Anderson,
and
A. Keys.
Densitometric analysis of body composition of men from girth measurements: revision of some quantitative assumptions.
Ann. NY Acad. Sci.
110:
113-140,
1963.
2.
Cappon, J. P.,
J. Brasel,
S. Mohan,
and
D. M. Cooper.
Effect of brief exercise on circulating insulin-like growth factor I.
J. Appl. Physiol.
76:
2490-2496,
1994
3.
Casanueva, F. F.,
L. Villanueva,
J. A. Cabranes,
J. Cabezas-Cerrato,
and
A. Fernandez-Cruz.
Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine and physical exercise in man.
J. Clin. Endocrinol. Metab.
59:
526-530,
1984[Abstract].
3a.
Food and Nutritional Boards, National Academy of Science-National Research Council.
Recommended Dietary Allowances (10th ed.). Washington, DC: National Academy, 1989.
4.
Friend, K.,
A. Iranmanesh,
and
J. D. Veldhuis.
The orderliness of the growth hormone (GH) release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days.
J. Clin. Endocrinol. Metab.
81:
3746-3753,
1996[Abstract].
5.
Giustina, A.,
and
J. D. Veldhuis.
Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human.
Endocr. Rev.
19:
717-797,
1998
6.
Gosselink, K. L.,
R. E. Grindeland,
R. R. Roy,
H. Zhong,
A. J. Bigbee,
E. J. Grossman,
and
V. R. Edgerton.
Skeletal muscle afferent regulation of bioassayable growth hormone in the rat pituitary.
J. Appl. Physiol.
84:
1425-1430,
1998
7.
Ho, K. Y.,
W. S. Evans,
R. M. Blizzard,
J. D. Veldhuis,
G. R. Merriam,
E. Samojlik,
R. Furlanetto,
A. D. Rogol,
D. L. Kaiser,
and
M. O. Thorner.
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations.
J. Clin. Endocrinol. Metab.
64:
51-58,
1987[Abstract].
8.
Hocking, R. R.
Methods and Applications of Linear Models: Regression and the Analysis of Variance. New York: Wiley, 1996.
9.
Howard, A. D.,
S. D. Feighner,
D. F. Cully,
J. P. Arena,
P. A. Liberator,
C. I. Rosenblum,
M. Hamelin,
D. L. Hreniuk,
A. C. Palyha,
J. Anderson,
P. S. Paress,
C. Diaz,
M. Chou,
K. K. Liu,
K. K. McKee,
S.-S. Pong,
L.-Y. Chaung,
A. Elbrecht,
M. Dashkevicz,
R. Heavens,
M. Rigby,
D. J. S. Sirinathsinghj,
D. C. Dean,
D. G. Melillo,
A. A. Paatchett,
R. Nargund,
P. R. Griffin,
J. A. Demartino,
S. K. Gupta,
J. M. Schaeffer,
R. G. Smith,
and
L. H. T. Van der Ploeg.
A receptor in pituitary and hypothalamus that functions in growth hormone release.
Science
273:
974-977,
1996[Abstract].
10.
Johnson, M. L.,
and
J. D. Veldhuis.
Evolution of deconvolution analysis as a hormone pulse detection method.
Methods Neurosci.
28:
1-24,
1995.
11.
Kanaley, J. A.,
J. Y. Weltman,
J. D. Veldhuis,
A. D. Rogol,
M. L. Hartman,
and
A. Weltman.
Human growth hormone response to repeated bouts of aerobic exercise.
J. Appl. Physiol.
83:
1756-1761,
1997
12.
Katch, F.,
E. D. Michael,
and
S. M. Horvath.
Estimation of body volume by underwater weighing: description of a single method.
J. Appl. Physiol.
23:
811-816,
1967
13.
Kuel, R. O.
Statistical Principles of Research Design and Analysis. Press Belmont, CA: Duxbury, 1994.
14.
Lang, I.,
G. Schernthaner,
P. Pietschmann,
R. Kurz,
J. M. Stephenson,
and
H. Templ.
Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals.
J. Clin. Endocrinol. Metab.
65:
535-540,
1987[Abstract].
15.
Lassarre, C.,
F. Girard,
J. Durand,
and
J. Raynaud.
Kinetics of human growth hormone during submaximal exercise.
J. Appl. Physiol.
37:
826-830,
1974
16.
Moretti, C.,
A. Favvri,
L. Gnessi,
M. Cappa,
A. Calzolari,
F. Fraioli,
A. Grossman,
and
G. M. Besser.
Naloxone inhibits exercise-induced release of PRL and GH in athletes.
Clin. Endocrinol. (Oxf.)
18:
135-138,
1983[Medline].
17.
Painson, J.-C.,
and
G. S. Tannenbaum.
Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
Endocrinology
128:
2858-2866,
1991[Abstract].
18.
Pincus, S. M.,
E. F. Gevers,
I. C. A. F. Robinson,
G. van den Berg,
F. Roelfsema,
M. L. Hartman,
and
J. D. Veldhuis.
Females secrete growth hormone with more process irregularity than males in both humans and rats.
Am. J. Physiol.
270 (Endocrinol. Metab. 33):
E107-E115,
1996
19.
Pong, S.-S.,
L.-Y. P. Chaung,
D. C. Dean,
R. P. Nargund,
A. A. Patchett,
and
R. G. Smith.
Identification of a new G-protein-linked receptor for growth hormone secretagogues.
Mol. Endocrinol.
10:
57-61,
1996[Abstract].
20.
Raynaud, J.,
A. Capderou,
J.-P. Martineaud,
B. Bordachar,
and
J. Durand.
Intersubject variability in growth hormone time course during different types of work.
J. Appl. Physiol.
55:
1682-1687,
1983
22.
Schaefer, F.,
G. Baumann,
L. M. Faunt,
D. Haffner,
M. L. Johnson,
M. Mercado,
E. Ritz,
O. Mehls,
and
J. D. Veldhuis.
Multifactorial control of the elimination kinetics of unbound (free) GH in the human: regulation by age, adiposity, renal function, and steady-state concentrations of GH in plasma.
J. Clin. Endocrinol. Metab.
81:
22-31,
1996[Abstract].
23.
Shah, N., W. S. Evans, and J. D. Veldhuis.
Time-mode of growth hormone (GH) entry into the bloodstream and
steady-state plasma GH concentrations rather than sex, estradiol or
menstrual-cycle stage primarily determine the GH elimination rate in
healthy young women and men. J. Clin. Endocrinol.
Metab. In press.
24.
Sutton, J.,
and
L. Lazarus.
Effect of adrenergic blocking agents on growth hormone responses to physical exercise.
Horm. Metab. Res.
6:
428-429,
1974[Medline].
25.
Sutton, J.,
and
L. Lazarus.
Growth hormone in exercise: comparison of physiological and pharmacological stimuli.
J. Appl. Physiol.
41:
523-527,
1976
26.
Thompson, D. L.,
J. Y. Weltman,
A. D. Rogol,
D. L. Metzger,
J. D. Veldhuis,
and
A. Weltman.
Cholinergic and opioid involvement in release of growth hormone during exercise and recovery.
J. Appl. Physiol.
75:
870-878,
1993
27.
Van den Berg, G.,
J. D. Veldhuis,
M. Frolich,
and
F. Roelfsema.
An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women.
J. Clin. Endocrinol. Metab.
81:
2460-2467,
1996[Abstract].
28.
Veldhuis, J. D.
The neuroendocrine regulation and implications of pulsatile GH secretion: gender effects.
Endocrinology
5:
198-213,
1995.
29.
Veldhuis, J. D.
What have we learned so far from ultra-sensitive GH assays?
Clin. Chem.
42:
1731-1732,
1998
30.
Veldhuis, J. D.,
M. L. Carlson,
and
M. L. Johnson.
The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations.
Proc. Natl. Acad. Sci. USA
84:
7686-7690,
1987
31.
Veldhuis, J. D.,
and
M. L. Johnson.
Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection.
Am. J. Physiol.
250 (Endocrinol. Metab. 13):
E486-E493,
1986
32.
Veldhuis, J. D.,
and
M. L. Johnson.
Specific methodological approaches to selected contemporary issues in deconvolution analysis of pulsatile neuroendocrine data.
Methods Neurosci.
28:
25-92,
1995.
33.
Veldhuis, J. D.,
A. Y. Liem,
S. South,
A. Weltman,
J. Y. Weltman,
D. A. Clemmons,
R. D. Abbott,
T. Mulligan,
M. L. Johnson,
S. Pincus,
M. Straume,
and
A. Iranmanesh.
Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay.
J. Clin. Endocrinol. Metab.
80:
3209-3222,
1995[Abstract].
34.
Weltman, A.,
D. Snead,
P. Stein,
R. Seip,
R. Schurrer,
R. Rutt,
and
J. Weltman.
Reliability and validity of a continuous incremental treadmill protocol for the determination of lactate threshold, fixed blood lactate concentrations and
O2 max.
Int. J. Sports Med.
11:
26-32,
1990[Medline].
35.
Weltman, A.,
J. Y. Weltman,
R. Schurrer,
W. S. Evans,
J. D. Veldhuis,
and
A. D. Rogol.
Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity.
J. Appl. Physiol.
72:
2188-2196,
1992
36.
Weltman, A.,
J. Y. Weltman,
C. J. Womack,
S. E. Davis,
J. L. Blummer,
G. A. Gaesser,
and
M. L. Hartman.
Exercise training decreases the growth hormone (GH) response to acute constant-load exercise.
Med. Sci. Sports Exerc.
29:
669-76,
1997[Medline].
37.
Wilmore, J. H.
A simplified method for the determination of residual lung volume.
J. Appl. Physiol.
27:
96-100,
1969
This article has been cited by other articles:
![]() |
J. Gibney, M.-L. Healy, and P. H. Sonksen The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport Endocr. Rev., October 1, 2007; 28(6): 603 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wideman, L. Consitt, J. Patrie, B. Swearingin, R. Bloomer, P. Davis, and A. Weltman The impact of sex and exercise duration on growth hormone secretion J Appl Physiol, December 1, 2006; 101(6): 1641 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Collier, E. Collins, and J. A. Kanaley Oral arginine attenuates the growth hormone response to resistance exercise J Appl Physiol, September 1, 2006; 101(3): 848 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weltman, J. Y. Weltman, C. P. Roy, L. Wideman, J. Patrie, W. S. Evans, and J. D. Veldhuis Growth hormone response to graded exercise intensities is attenuated and the gender difference abolished in older adults J Appl Physiol, May 1, 2006; 100(5): 1623 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A Kanaley, I Giannopoulou, S Collier, R Ploutz-Snyder, and R Carhart Jr Hormone-replacement therapy use, but not race, impacts the resting and exercise-induced GH response in postmenopausal women Eur. J. Endocrinol., October 1, 2005; 153(4): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. Patrie, L. Wideman, M. Patterson, J. Y. Weltman, and A. Weltman Contrasting Negative-Feedback Control of Endogenously Driven and Exercise-Stimulated Pulsatile Growth Hormone Secretion in Women and Men J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 840 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ehrnborg, K. H. W. Lange, R. Dall, J. S. Christiansen, P.-A. Lundberg, R. C. Baxter, M. A. Boroujerdi, B.-A. Bengtsson, M.-L. Healey, C. Pentecost, et al. The Growth Hormone/Insulin-Like Growth Factor-I Axis Hormones and Bone Markers in Elite Athletes in Response to a Maximum Exercise Test J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 394 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cohen, G. M. Bright, A. D. Rogol, A.-M. Kappelgaard, and R. G. Rosenfeld Effects of Dose and Gender on the Growth and Growth Factor Response to GH in GH-Deficient Children: Implications for Efficacy and Safety J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 90 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Galassetti, S. Mann, D. Tate, R. A. Neill, D. H. Wasserman, and S. N. Davis Effect of morning exercise on counterregulatory responses to subsequent, afternoon exercise J Appl Physiol, July 1, 2001; 91(1): 91 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wideman, J. Y. Weltman, J. T. Patrie, C. Y. Bowers, N. Shah, S. Story, A. Weltman, and J. D. Veldhuis Synergy of L-arginine and growth hormone (GH)-releasing peptide-2 on GH release: influence of gender Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1455 - R1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wideman, J. Y. Weltman, J. T. Patrie, C. Y. Bowers, N. Shah, S. Story, J. D. Veldhuis, and A. Weltman Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1467 - R1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weltman, C. J. Pritzlaff, L. Wideman, J. Y. Weltman, J. L. Blumer, R. D. Abbott, M. L. Hartman, and J. D. Veldhuis Exercise-dependent growth hormone release is linked to markers of heightened central adrenergic outflow J Appl Physiol, August 1, 2000; 89(2): 629 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, and A. D. Rogol Gender and Sexual Maturation-Dependent Contrasts in the Neuroregulation of Growth Hormone Secretion in Prepubertal and Late Adolescent Males and Females--A General Clinical Research Center-Based Study J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2385 - 2394. [Abstract] [Full Text] |
||||
![]() |
C. J. Pritzlaff-Roy, L. Widemen, J. Y. Weltman, R. Abbott, M. Gutgesell, M. L. Hartman, J. D. Veldhuis, and A. Weltman Gender governs the relationship between exercise intensity and growth hormone release in young adults J Appl Physiol, May 1, 2002; 92(5): 2053 - 2060. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||